- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01178463
Spermatogonial Stem Cells in Azoospermic Patients: a Comparison Between Obstructive and Non-obstructive Azoospermia
August 9, 2010 updated by: Hillel Yaffe Medical Center
The researchers hypothesized that nonobstructive azoospermia might be associated with a reduction OF SSCs in seminiferous tubules as compared with obstructive azoospermia.
Testicular sperm specimens that had been previously extracted from azoospermic patients will be paraffin embedded and stained with anti GPR-125.
After antigen retrieval, the sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit secondary antibodies.
Those found to be SSCs will be counted using light microscopy, and compared between patients with obstructive (n=11) and non-obstructive azoospermia (n=9).
Study Overview
Study Type
Observational
Enrollment (Anticipated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center - IVF Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Infertile male patients treated at the Hillel Yaffe Medical Center IVF Unit
Description
Inclusion Criteria:
- Azoospermic patients
Exclusion Criteria:
- Patients with sperm cells
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
I. Obstructive Azoospermia
|
The sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit secondary antibodies.
|
II. Non-Obstructive Azoospermia Patients
|
The sections will be incubated with rabbit anti GPR125 followed by Cy3-conjugated anti rabbit secondary antibodies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
SSCs were identified in both obstructive and nonobstructive azoospermia patients.
Time Frame: One year
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
May 1, 2010
Study Completion (Anticipated)
October 1, 2010
Study Registration Dates
First Submitted
August 9, 2010
First Submitted That Met QC Criteria
August 9, 2010
First Posted (Estimate)
August 10, 2010
Study Record Updates
Last Update Posted (Estimate)
August 10, 2010
Last Update Submitted That Met QC Criteria
August 9, 2010
Last Verified
August 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HYMC-0065-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Reproductive Medicine Associates of New JerseyTerminated
-
Jinling Hospital, ChinaRecruitingMale Infertility Due to HypospermatogenesisChina
-
Sapientiae InstituteTerminated
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Hillel Yaffe Medical CenterUnknownMale Infertility With Severe Oligo-terato-asteno-spermiaIsrael
-
Assiut UniversityNot yet recruitingMale Infertility Due to Azoospermia
-
Universitair Ziekenhuis BrusselRecruitingMale InfertilityBelgium
Clinical Trials on Biospecimen staining
-
Xuanwu Hospital, BeijingNot yet recruitingEncephalitis | Meningitis | Central Nervous System (CNS) InfectionChina
-
Port Said University hospitalMansoura University HospitalCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalUnknown
-
WellSpan HealthActive, not recruitingEndometrial Hyperplasia | Lynch Syndrome | Endometrial Cancer | Microsatellite Instability | Mismatch Repair DeficiencyUnited States
-
Universitas Katolik Widya Mandala SurabayaIndonesia's Ministry of Research and Technology (Ristekdikti/BRIN)CompletedImmune Defect | Lymphadenitis, TuberculousIndonesia
-
St. Justine's HospitalRecruitingHirschsprung Disease | Ganglion | Hirschsprung Disease, Long-Segment | HypoganglionosisCanada
-
Hillel Yaffe Medical CenterUnknown
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the SkinGermany
-
Kahramanmaras Sutcu Imam UniversityCompletedTriple Negative Breast Cancer | Carbonic Anhydrase IXTurkey
-
Samsung Medical CenterCompletedMalignant Lymphoma | P13K-AKT Pathway DeregulationKorea, Republic of